David Waldman | IR |
Jan D’Alvise | President and CEO |
Pierre Lemieux | COO, Chief Scientific Officer and Co-Founder |
Brian Groch | Chief Commercial Officer |
Jean-François Boily | VP, Finance |
Leland Gershell | Oppenheimer |
Toby Ma | Mackie Research |
Ladies and gentlemen, Hello and thank you all for your patience and for joining today’s Acasti Pharma Third Quarter 2020 Business Update Conference Call. All participants are in a listen-only mode, but you will have an opportunity to ask questions after today’s prepared remarks. Today’s session is being recorded.
And with that, I am pleased to turn the floor over to Mr. David Waldman with Investor Relations.